Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 59,700 shares at $51.98 ($3.1M) on 2020-12-08, disclosed to the SEC on 2020-12-09.
Open-market sale of $3.1M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.88 | 20,256 | $1.0M | 33.7% |
| 2 | $50.88 | 20,256 | $1.0M | 33.7% |
| 3 | $51.98 | 9,444 | $491K | 16.0% |
| 4 | $51.98 | 9,444 | $491K | 16.0% |
| 5 | $52.38 | 300 | $16K | 0.5% |
| Total | $51.24 avg | 59,700 |
| $3.1M |
| 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |